NCT07016789View on ClinicalTrials.gov

Cerebral Regional Oxygen Saturation During TAVI - The CROS-TAVI Prospective Registry

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Aortic Stenosis DiseaseTAVI(Transcatheter Aortic Valve Implantation)Cerebral Oxygen SaturationHemodynamic Changes
Interventions
DEVICE

Near-infrared spectroscopy monitoring (NIRS) INVOS 5100C

Continuous bilateral cerebral oxygen saturation monitoring using near-infrared spectroscopy (NIRS) during TAVI. Sensors are placed on the forehead to record rSO₂ values at predefined timepoints. Device used: INVOS 5100C (Medtronic/Covidien).

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT07016789 - Cerebral Regional Oxygen Saturation During TAVI - The CROS-TAVI Prospective Registry | Biotech Hunter | Biotech Hunter